An Austrian scientist says a sample of composer Ludwig van Beethoven's hair taken after his death indicates medical treatment hastened his death.
Christian Reiter of the Medical University of Vienna, Austria, says the amount of lead in Beethoven's bloodstream spiked every time his abdomen was punctured by a needle to drain fluid that may have been the result of cirrhosis, ScienceNOW Daily News reported Wednesday.
Reiter said lead salts used to clean the wound at the time of each puncture were probably to blame for the higher lead content in the composer's blood. He said the worsened lead poisoning probably contributed to Beethoven's cirrhosis and speeded up its progress until his death.
William Walsh, director of research at the Health Research Institute and Pfeiffer Treatment Center in Warrenville, Ill., has also conducted studies on Beethoven's hair, but came up with different lead levels in some cases then Reiter did. He said he will work with the other scientist to reach a consensus.
"The medical doctor actually may have killed (Beethoven) with lead poisoning," Walsh said.
Copyright 2007 by United Press International
Related stories:
Pill that boosts productivity gaining favor, raising concerns among medical ethicists
In a place like Silicon Valley, where career prospects often hinge on a person's intelligence and ability to work hellishly long hours, "brain doping" probably was inevitable.
Creating lung cancer risk models for specific populations refines prediction
Lung cancer risk prediction models are enhanced by taking into account risk factors by race and by measuring DNA repair capacity, according to research teams led by epidemiologists at The University of Texas M. D. Anderson Cancer Center in two complementary papers appearing in the September issue of
Cancer Prevention Research.
1 step back ... 2 steps forward
Women with hormone-receptor positive, metastatic breast cancer may take medications for years to help keep their cancer at bay, but when the tumor becomes resistant to anti-hormonal drugs, treatment with chemotherapy becomes the only option. But a study presented today at the 2008 ASCO Breast Cancer Symposium may change this approach. Early data suggests a new treatment approach can "re-sensitize" the tumor, allowing anti-hormonal drugs to do their job once again.
Updated guidelines for stem cell research released
The National Academies today released amended guidelines for research involving human embryonic stem cells, revising those that were issued in 2005 and updated in 2007. The Academies originally produced the guidelines to offer a common set of ethical standards for the responsible conduct of research using human stem cells, an area that, due to an absence of comprehensive federal funding, was lacking national standards. Since their initial release, the guidelines have served effectively as the basis for oversight of this research in the United States. In addition, a standing advisory committee -- a joint project between the Academies' National Research Council and Institute of Medicine -- was established to monitor and review scientific advances and determine any need for revisions.
Free drug samples may end up costing uninsured more
Free drug samples provided to physicians by pharmaceutical companies could actually be costing uninsured patients more in the long run, according to a study done by researchers at Wake Forest University Baptist Medical Center and colleagues.
A light bulb and a few chemicals: Scientists find a way to help make new reactions
(PhysOrg.com) -- Princeton scientists have discovered a way of stimulating organic molecules that they expect will prompt researchers to create materials from new kinds of chemical reactions.
You can be replaced: Immune cells compensate for defective DNA repair factor
A new mouse model has provided some surprising insight into XLF, a molecule that helps to repair lethal DNA damage. The research, published by Cell Press in the September 5th issue of the journal
Molecular Cell, suggests that although XLF shares many properties with well known DNA repair factors, certain cells of the immune system possess an unexpected compensatory mechanism that that can take over for nonfunctional XLF.
Defibrillators save lives, don't diminish quality of life
Implantable cardioverter-defibrillators (ICDs) reduce the risk of death from sudden cardiac arrest (SCA) among patients with heart failure, and they do so without significantly altering a person's quality of life, say researchers from Duke University Medical Center.